| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | Australia | 1 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Singapore | 1 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hynd George | 10 |
| #2 | Sutton Jon | 10 |
| #3 | Whittaker Ben | 8 |
| #4 | Reynolds Charles | 8 |
| #5 | Knight Jamie | 8 |
| #6 | Keenan Richard M | 8 |
| #7 | Maly Dustin J | 8 |
| #8 | Backes Bradley J | 8 |
| #9 | Oakes Scott A | 6 |
| #10 | Papa Feroz R | 6 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020176765A1 | Pyrazolopyridine compounds for ire1 inhibition | |
| WO2020176761A1 | Imidazolopyrazine compounds for ire1 inhibition | |
| CA3074139A1 | Compounds and compositions for ire1 inhibition |